The first UK research study into the medical benefits of cannabis on Multiple Scelrosis has shown there is no benefit.
However there were benefits for those at the lower end of the disability scale.
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study was carried out by researchers from the Peninsula College of Medicine and Dentistry.
It enrolled nearly 500 people with MS from 27 centres around the UK, who were either given capsules containing the active ingredient of cannabis and some given a placebo.
Alison Smith, an MS sufferer took part in the trial:
More top news
The mayor of Paris has called for a black feminist festival in the French capital to be banned because it "prohibited white people".
More than 200 drivers a day were caught using their mobile phones illegally in the wake of a major crackdown on the practice.
Tougher sentences will be handed out to perpetrators of domestic violence against children under plans being set out by the Conservatives.